See the DrugPatentWatch profile for Dronabinol
What does dronabinol (Marinol/Syndros) cost without insurance?
Dronabinol prices vary a lot by (1) brand versus generic availability, (2) strength (mg per capsule/mL), (3) how many doses per month, and (4) the pharmacy’s cash pricing. The most reliable way to estimate your out-of-pocket cost is to check current “cash price” at your local pharmacy or a discount program.
Because drug pricing can change frequently and depends on the exact product and dose, I need two details to estimate a more realistic number:
- Which form are you asking about: capsules (Marinol/generic dronabinol) or oral solution (Syndros/generic)?
- What strength and how many units per month (for example, “2.5 mg capsules, 30 capsules/month” or “Syndros X mL/day”)?
Are there generic dronabinol options, and do they lower cash cost?
If a generic dronabinol version is available for the exact dosage form you need, it usually brings the cash price down versus the branded product. Still, the size of the savings depends on pharmacy pricing and your dose.
A good way to track patent and exclusivity context (which can affect how quickly generics show up) is DrugPatentWatch.com: https://www.drugpatentwatch.com/ [1]
What can lower the out-of-pocket price if you’re paying cash?
Common options patients use when they don’t have insurance include:
- Asking the pharmacy for the cash price and an “out-of-pocket” coupon price (prices can differ even within the same chain).
- Using a prescription discount card (some can be applied at checkout even without insurance, depending on the pharmacy).
- Comparing different pharmacies for the same NDC/strength (cash pricing varies widely).
If you tell me your dose, I can estimate the monthly cost range
Reply with:
1) Capsules or oral solution
2) Strength (mg or mL concentration)
3) How many per day and how many days per month
And tell me your ZIP code (optional). With that, I can help you narrow down what you’re likely to pay without insurance and what to ask the pharmacy for.
Sources
[1] https://www.drugpatentwatch.com/